These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26926380)

  • 21. The timed 25-foot walk in a large cohort of multiple sclerosis patients.
    Kalinowski A; Cutter G; Bozinov N; Hinman JA; Hittle M; Motl R; Odden M; Nelson LM
    Mult Scler; 2022 Feb; 28(2):289-299. PubMed ID: 34100297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision making.
    van Munster CEP; Kaya L; Lam KH; Kalkers NF; Killestein J; Uitdehaag BMJ
    Mult Scler Relat Disord; 2020 Feb; 38():101489. PubMed ID: 31731213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative sensory and motor measures detect change overtime and correlate with walking speed in individuals with multiple sclerosis.
    Zackowski KM; Wang JI; McGready J; Calabresi PA; Newsome SD
    Mult Scler Relat Disord; 2015 Jan; 4(1):67-74. PubMed ID: 25692092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.
    Stellmann JP; Vettorazzi E; Poettgen J; Heesen C
    J Neurol Sci; 2014 Nov; 346(1-2):99-106. PubMed ID: 25156343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS.
    Hobart J; Blight AR; Goodman A; Lynn F; Putzki N
    Neurology; 2013 Apr; 80(16):1509-17. PubMed ID: 23535489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of multi-function swing suspension training on upper and lower extremities function and quality of life in multiple sclerosis women with different disability status.
    Far SS; Amiri B; Sahebozamani M; Ebrahimi HA; Zemková E
    Mult Scler Relat Disord; 2023 Dec; 80():105113. PubMed ID: 37924713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
    Voloshyna N; Havrdová E; Hutchinson M; Nehrych T; You X; Belachew S; Hotermans C; Paes D
    Eur J Neurol; 2015 Mar; 22(3):570-7. PubMed ID: 25511792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fear of falling, not falls, impacts leisure-time physical activity in people with multiple sclerosis.
    Kalron A; Aloni R; Givon U; Menascu S
    Gait Posture; 2018 Sep; 65():33-38. PubMed ID: 30558943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overground Robotic Program Preserves Gait in Individuals With Multiple Sclerosis and Moderate to Severe Impairments: A Randomized Controlled Trial.
    Berriozabalgoitia R; Bidaurrazaga-Letona I; Otxoa E; Urquiza M; Irazusta J; Rodriguez-Larrad A
    Arch Phys Med Rehabil; 2021 May; 102(5):932-939. PubMed ID: 33316225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multidimensional assessment of multiple sclerosis: relationships between disability domains.
    Provinciali L; Ceravolo MG; Bartolini M; Logullo F; Danni M
    Acta Neurol Scand; 1999 Sep; 100(3):156-62. PubMed ID: 10478578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosis.
    de David AC; Sasaki JE; Ramari C; Tauil CB; Moraes AG; Martins F; von Glehn F; Motl RW
    Mult Scler Relat Disord; 2019 May; 30():208-214. PubMed ID: 30818129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An enrichment strategy for clinical trials in SPMS.
    Koch MW; Metz L; Cutter G
    Mult Scler; 2021 Oct; 27(12):1884-1893. PubMed ID: 33404355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set.
    Gijbels D; Dalgas U; Romberg A; de Groot V; Bethoux F; Vaney C; Gebara B; Medina CS; Maamâgi H; Rasova K; de Noordhout BM; Knuts K; Feys P
    Mult Scler; 2012 Mar; 18(3):364-71. PubMed ID: 21952098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis.
    Phan-Ba R; Calay P; Grodent P; Delrue G; Lommers E; Delvaux V; Moonen G; Belachew S
    PLoS One; 2012; 7(4):e34744. PubMed ID: 22514661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world.
    Goldman MD; Motl RW; Scagnelli J; Pula JH; Sosnoff JJ; Cadavid D
    Neurology; 2013 Nov; 81(21):1856-63. PubMed ID: 24174581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Walking speed and economic outcomes for walking-impaired patients with multiple sclerosis.
    Cohen JT
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):595-603. PubMed ID: 20950074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis.
    Coleman CI; Sobieraj DM; Marinucci LN
    Curr Med Res Opin; 2012 Jan; 28(1):49-56. PubMed ID: 22073939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-efficacy and Walking Performance in Persons With Multiple Sclerosis.
    Motl RW; Balto JM; Ensari I; Hubbard EA
    J Neurol Phys Ther; 2017 Apr; 41(2):114-118. PubMed ID: 28263255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets.
    Koch MW; Mostert J; Uitdehaag B; Cutter G
    Mult Scler; 2020 Oct; 26(12):1540-1549. PubMed ID: 31517591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.